Insider · CIK 0001224096

EISENBERG JEFFREY F

Reports to the SEC for 3 companies · MIAMI, FL

sec.gov

Transactions

Companies

Filings

CIK

0001224096

Forms 4 and 5

Insider transactions

43 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-12-11	XBIOXenetic Biosciences, Inc. · Stock OptionsA Award	Director, Chief Executive Officer	AAward	+20K sh	—	—	20,000
2022-03-24	XBIOXenetic Biosciences, Inc. · Stock OptionsA Award	Director, Chief Executive Officer	AAward	+100K sh	—	—	100,000
2021-03-18	XBIOXenetic Biosciences, Inc. · Stock OptionsA Award	Director, Chief Executive Officer	AAward	+100K sh	—	—	100,000
2019-12-04	XBIOXenetic Biosciences, Inc. · Stock OptionsA Award	Director, Chief Executive Officer	AAward	+230K sh	—	—	230,000
2018-02-21	MABVAX THERAPEUTICS HOLDINGS, INC.Option to Purchase Common StockA Award	Director	AAward	+35K sh	—	—	35,000
2018-01-24	MABVAX THERAPEUTICS HOLDINGS, INC.S Sale	Director	SSale	−18K sh	$0.84	−$15.1K	64,558
2018-01-23	MABVAX THERAPEUTICS HOLDINGS, INC.S Sale	Director	SSale	−17.4K sh	$0.87	−$15.2K	82,556
2017-10-26	XBIOXenetic Biosciences, Inc.A Award	Director, Chief Executive Officer	AAward	+50K sh	—	—	50,000
2017-10-26	XBIOXenetic Biosciences, Inc. · Stock OptionsA Award	Director, Chief Executive Officer	AAward	+250K sh	—	—	250,000
2017-10-02	MABVAX THERAPEUTICS HOLDINGS, INC.Restricted Stock UnitA Award	Director	AAward	+75.8K sh	—	—	75,790
2017-09-15	MABVAX THERAPEUTICS HOLDINGS, INC.Restricted Stock UnitA Award	Director	AAward	+24.2K sh	—	—	24,210
2017-06-12	MABVAX THERAPEUTICS HOLDINGS, INC.Option to Purchase Common StockA Award	Director	AAward	+20K sh	$1.57	+$31.4K	20,000
2017-05-19	MABVAX THERAPEUTICS HOLDINGS, INC.Option to Purchase Common StockA Award	Director	AAward	+50K sh	$1.80	+$90K	50,000
2017-01-01	MABVAX THERAPEUTICS HOLDINGS, INC.Option to Purchase Common StockA Award	Director	AAward	+2,300 sh	$3.38	+$7,774	2,300
2016-12-02	XBIOXenetic Biosciences, Inc. · Stock OptionsA Award	Director, Chief Executive Officer	AAward	+4,700 sh	—	—	4,700
2016-12-02	XBIOXenetic Biosciences, Inc. · Stock OptionsA Award	Director, Chief Executive Officer	AAward	+75.1K sh	—	—	79,800
2016-12-02	XBIOXenetic Biosciences, Inc. · Stock OptionsA Award	Director, Chief Executive Officer	AAward	+75.1K sh	—	—	154,900
2016-12-02	XBIOXenetic Biosciences, Inc. · Stock OptionsA Award	Director, Chief Executive Officer	AAward	+75.1K sh	—	—	230,000
2016-08-29	MABVAX THERAPEUTICS HOLDINGS, INC.Option to Purchase Common StockA Award	Director	AAward	+2,300 sh	$5.00	+$11.5K	2,300
2016-06-29	MABVAX THERAPEUTICS HOLDINGS, INC.Option to Purchase Common StockA Award	Director	AAward	+35K sh	$0.55	+$19.3K	35,000
2009-08-27	NOVEN PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Executive Vice President	DDisposition to Issuer	−30.9K sh	—	—	0
2009-08-27	NOVEN PHARMACEUTICALS INCD Disposition to Issuer	Executive Vice President	DDisposition to Issuer	−1,835 sh	$16.50	−$30.3K	0
2009-08-27	NOVEN PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Executive Vice President	DDisposition to Issuer	−19.1K sh	—	—	0
2009-08-27	NOVEN PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Executive Vice President	DDisposition to Issuer	−24K sh	—	—	0
2009-08-27	NOVEN PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Executive Vice President	DDisposition to Issuer	−50K sh	—	—	0
2009-08-27	NOVEN PHARMACEUTICALS INCStock Appreciation RightD Disposition to Issuer	Executive Vice President	DDisposition to Issuer	−23.5K sh	—	—	0
2009-08-27	NOVEN PHARMACEUTICALS INCStock Appreciation RightD Disposition to Issuer	Executive Vice President	DDisposition to Issuer	−52.2K sh	—	—	0
2009-08-27	NOVEN PHARMACEUTICALS INCStock Appreciation RightD Disposition to Issuer	Executive Vice President	DDisposition to Issuer	−71.7K sh	—	—	0
2009-08-20	NOVEN PHARMACEUTICALS INCU Disposition from Tender	Executive Vice President	UDisposition from Tender	−11.8K sh	$16.50	−$195K	1,835
2008-01-02	NOVEN PHARMACEUTICALS INCA Award	Executive Vice President	AAward	+7,342 sh	—	—	13,681
2006-12-11	NOVEN PHARMACEUTICALS INCS Sale	Executive Vice President	SSale	−2,500 sh	$25.45	−$63.6K	15,839
2006-12-11	NOVEN PHARMACEUTICALS INCS Sale	Executive Vice President	SSale	−2,000 sh	$25.45	−$50.9K	13,839
2006-12-11	NOVEN PHARMACEUTICALS INCS Sale	Executive Vice President	SSale	−2,500 sh	$25.40	−$63.5K	11,339
2006-12-11	NOVEN PHARMACEUTICALS INCS Sale	Executive Vice President	SSale	−2,500 sh	$25.39	−$63.5K	8,839
2006-12-11	NOVEN PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	Executive Vice President	MExercise/Conversion	−12K sh	—	—	24,000
2006-12-11	NOVEN PHARMACEUTICALS INCS Sale	Executive Vice President	SSale	−2,500 sh	$25.32	−$63.3K	6,339
2006-12-11	NOVEN PHARMACEUTICALS INCM Exercise/Conversion	Executive Vice President	MExercise/Conversion	+12K sh	$10.45	+$125K	18,539
2006-03-15	NOVEN PHARMACEUTICALS INCS Sale	Executive Vice President	SSale	−2,000 sh	$17.31	−$34.6K	7,400
2006-03-15	NOVEN PHARMACEUTICALS INCS Sale	Executive Vice President	SSale	−4,000 sh	$17.36	−$69.5K	3,400
2006-03-15	NOVEN PHARMACEUTICALS INCStock Options (Right to Buy)M Exercise/Conversion	Executive Vice President	MExercise/Conversion	−9,500 sh	—	—	5,100
2006-03-15	NOVEN PHARMACEUTICALS INCS Sale	Executive Vice President	SSale	−3,500 sh	$17.28	−$60.5K	9,400
2006-03-15	NOVEN PHARMACEUTICALS INCM Exercise/Conversion	Executive Vice President	MExercise/Conversion	+9,500 sh	$8.81	+$83.7K	12,900
2003-11-05	NOVEN PHARMACEUTICALS INCStock Option (Right to Buy)A Award	Executive Vice President	AAward	+60K sh	—	—	60,000

Recent filings

Accepted (ET)
Dec 134
EISENBERG JEFFREY F0001683168-23-008824
SEC(opens sec.gov)
Mar 284
EISENBERG JEFFREY F0001683168-22-002000
SEC(opens sec.gov)
Mar 224
EISENBERG JEFFREY F0001683168-21-001018
SEC(opens sec.gov)
Dec 64
EISENBERG JEFFREY F0001683168-19-003915
SEC(opens sec.gov)
Feb 234
EISENBERG JEFFREY F0001415889-18-000308
SEC(opens sec.gov)
Jan 244
EISENBERG JEFFREY F0001415889-18-000120
SEC(opens sec.gov)
Oct 304
EISENBERG JEFFREY F0001662252-17-000220
SEC(opens sec.gov)
Oct 44
EISENBERG JEFFREY F0001415889-17-001618
SEC(opens sec.gov)
Sep 184
EISENBERG JEFFREY F0001415889-17-001505
SEC(opens sec.gov)
Jun 144
MABVAX THERAPEUTICS HOLDINGS, INC.0001415889-17-000980
SEC(opens sec.gov)
May 234
MABVAX THERAPEUTICS HOLDINGS, INC.0001415889-17-000844
SEC(opens sec.gov)
Jan 34
MABVAX THERAPEUTICS HOLDINGS, INC.0001415889-17-000027
SEC(opens sec.gov)
Dec 64
Xenetic Biosciences, Inc.0001662252-16-000276
SEC(opens sec.gov)
Aug 304
MABVAX THERAPEUTICS HOLDINGS, INC.0001415889-16-007004
SEC(opens sec.gov)
Jul 284
MABVAX THERAPEUTICS HOLDINGS, INC.0001415889-16-006614
SEC(opens sec.gov)

Companies

Address

C/O NOVEN PHARMACEUTICALS, INC. 11960 S.W. 144TH STREET

MIAMI, FL, 33186